bioRxiv Science⌕ Search

Biology subjects

Ulery, B.

Publications and source records attributed to Ulery, B..

2 recordsLinked to original sources

Development of properly-polarized trophoblast stem cell-derived organoids to model early human pregnancy

The development of human trophoblast stem cells (hTSC) and stem cell-derived trophoblast organoids has enabled investigation of placental physiology and disease and early maternal-fetal interactions during a stage of human pregnancy that previously had been severely restricted. A key shortcoming in existing trophoblast organoid methodologies is the non-physiologic position of the syncytiotrophoblast (STB) within the inner portion of the organoid, which neither recapitulates placental villous morphology in vivo nor allows for facile modeling of STB exposure to the endometrium or the contents of the intervillous space. Here we have successfully established properly-polarized human trophoblast stem cell (hTSC)-sourced organoids with STB forming on the surface of the organoid. These organoids can also be induced to give rise to the extravillous trophoblast (EVT) lineage with HLA-G+ migratory cells that invade into an extracellular matrix-based hydrogel. Compared to previous hTSC organoid methods, organoids created by this method more closely mimic the architecture of the developing human placenta and provide a novel platform to study normal and abnormal human placental development and to model exposures to pharmaceuticals, pathogens and environmental insults. MotivationHuman placental organoids have been generated to mimic physiological cell-cell interactions. However, those published models derived from human trophoblast stem cells (hTSCs) or placental villi display a non-physiologic "inside-out" morphology. In vivo, the placental villi have an outer layer of syncytialized cells that are in direct contact with maternal blood, acting as a conduit for gas and nutrient exchange, and an inner layer of progenitor, single cytotrophoblast cells that fuse to create the syncytiotrophoblast layer. Existing "inside-out" models put the cytotrophoblast cells in contact with culture media and substrate, making physiologic interactions between syncytiotrophoblast and other cells/tissues and normal and pathogenic exposures coming from maternal blood difficult to model. The goal of this study was to develop an hTSC-derived 3-D human trophoblast organoid model that positions the syncytiotrophoblast layer on the outside of the multicellular organoid. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=69 SRC="FIGDIR/small/560327v1_ufig1.gif" ALT="Figure 1"> View larger version (24K): org.highwire.dtl.DTLVardef@7f1e7forg.highwire.dtl.DTLVardef@1ab41d9org.highwire.dtl.DTLVardef@7046d5org.highwire.dtl.DTLVardef@13a7542_HPS_FORMAT_FIGEXP M_FIG C_FIG

developmental biology↗

Controlled Hydrogen Sulfide Delivery to Enhance Cell Survival in Bone Tissue Engineering

The increased local concentration of calcium ions (Ca2+) and phosphate (Pi), a natural body process for bone healing and remodeling, as well as local delivery of these ions as signaling molecules by synthetic bone graft substitutes, may lead to cytotoxic ion levels that can result in Ca2+/ Pi mitochondria overload, oxidative stress, and cell death. In this research, the effect of H2S as a cytoprotective signaling molecule to increase the tolerance of mesenchymal stem cells (MSCs) in the presence of cytotoxic level of Ca2+/Pi was evaluated. Different concentrations of sodium hydrogen sulfide (NaSH), a fast-releasing H2S donor, were exposed to cells in order to evaluate the influence of H2S on MSC proliferation. The results suggested that a range of NaSH (i.e., 0.25 - 4 mM NaSH) was non-cytotoxic and could improve cell proliferation and differentiation in the presence of cytotoxic levels of Ca2+ (32 mM) and/or Pi (16 mM). To controllably deliver H2S over time, a novel donor molecule in thioglutamic acid (GluSH) was synthesized and evaluated for its H2S release profile. Excitingly, GluSH successfully maintained cytoprotective level of H2S over 7 days. Furthermore, MSCs exposed to cytotoxic Ca2+/Pi concentrations in the presence of GluSH were able to thrive and differentiate into osteoblasts. These findings suggest that the incorporation of a sustained H2S donor such as GluSH into CaP-based bone substitutes can facilitate considerable cytoprotection making it an attractive option for complex bone regenerative engineering applications.

bioengineering↗